Tillman Gerngross is the founder of Adimab. Adimab has raised $50M in total funding. Based in Lebanon, New Hampshire, USA.
Tillman Gerngross is a Dartmouth College engineering professor and biotechnology entrepreneur. He founded Adimab, an antibody discovery company, and later Adagio Therapeutics to advance clinical trials for antibodies against SARS-CoV-2. He is known for his work in engineering antibodies to combat coronaviruses.
Full founder directory · Investor directory · Company funding database · Fundraising library